An artificial intelligence/machine learning approach to predicting anti-seizure medication efficacy in Dravet syndrome
A major challenge in the management of many epilepsies, including Dravet syndrome (DS), is the prolonged trial and error approach of determining whether or not a specific antiseizure medication (ASM) will work for a given patient. Testing an add-on therapy can take many months before it is determined to be ineffective, and for some it […]